AU2001268399A1 - Toxicity typing using mesenchymal stem cells - Google Patents

Toxicity typing using mesenchymal stem cells

Info

Publication number
AU2001268399A1
AU2001268399A1 AU2001268399A AU6839901A AU2001268399A1 AU 2001268399 A1 AU2001268399 A1 AU 2001268399A1 AU 2001268399 A AU2001268399 A AU 2001268399A AU 6839901 A AU6839901 A AU 6839901A AU 2001268399 A1 AU2001268399 A1 AU 2001268399A1
Authority
AU
Australia
Prior art keywords
stem cells
mesenchymal stem
typing
toxicity
toxicity typing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001268399A
Inventor
H. Ralph Snodgrass
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vistagen Inc
Original Assignee
Vistagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vistagen Inc filed Critical Vistagen Inc
Publication of AU2001268399A1 publication Critical patent/AU2001268399A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2001268399A 2000-06-14 2001-06-14 Toxicity typing using mesenchymal stem cells Abandoned AU2001268399A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21160800P 2000-06-14 2000-06-14
US60211608 2000-06-14
PCT/US2001/019048 WO2001096865A1 (en) 2000-06-14 2001-06-14 Toxicity typing using mesenchymal stem cells

Publications (1)

Publication Number Publication Date
AU2001268399A1 true AU2001268399A1 (en) 2001-12-24

Family

ID=22787629

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001268399A Abandoned AU2001268399A1 (en) 2000-06-14 2001-06-14 Toxicity typing using mesenchymal stem cells

Country Status (8)

Country Link
US (1) US20020045179A1 (en)
EP (1) EP1290443A1 (en)
JP (1) JP2004503255A (en)
KR (1) KR20030009531A (en)
AU (1) AU2001268399A1 (en)
CA (1) CA2412769A1 (en)
HK (1) HK1054981A1 (en)
WO (1) WO2001096865A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60140120D1 (en) 2000-06-14 2009-11-19 Vistagen Inc TOXICITY TYPING USING LIVESTOCK CELLS
EP1536229A1 (en) * 2003-11-26 2005-06-01 Plant Research International B.V. Method to identify a biomolecular profile
US7795390B2 (en) 2005-06-24 2010-09-14 Teijin Pharma Limited Biological substance nesfatin and its related substances and uses thereof
CN105044367A (en) * 2015-08-03 2015-11-11 武汉上成生物科技有限公司 Colloidal gold immunochromatographic assay test strip for detecting dexamethasone residues in milk
CN109735431A (en) * 2019-02-19 2019-05-10 深圳市刚竹医疗科技有限公司 Centrifugal microfluidic control chip and foranalysis of nucleic acids system

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997013877A1 (en) * 1995-10-12 1997-04-17 Lynx Therapeutics, Inc. Measurement of gene expression profiles in toxicity determination
US5811297A (en) * 1996-03-07 1998-09-22 Amba Biosciences, Llc Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, & in vitro generation of dendritic cells and macrophages
AU9200298A (en) * 1997-08-22 1999-03-16 Yale University A process to study changes in gene expression in stem cells
WO1999027090A1 (en) * 1997-11-20 1999-06-03 Smithkline Beecham Corporation Methods for identifying the toxic/pathologic effect of environmental stimuli on gene transcription
CA2318789C (en) * 1998-02-25 2011-05-10 The United States Of America As Represented By The Secretary Department Of Health And Human Services Cellular arrays for rapid molecular profiling
WO2000029002A2 (en) * 1998-11-13 2000-05-25 Osiris Therapeutics, Inc. In utero transplantation of human mesenchymal stem cells

Also Published As

Publication number Publication date
KR20030009531A (en) 2003-01-29
US20020045179A1 (en) 2002-04-18
JP2004503255A (en) 2004-02-05
CA2412769A1 (en) 2001-12-20
EP1290443A1 (en) 2003-03-12
WO2001096865A1 (en) 2001-12-20
HK1054981A1 (en) 2003-12-19

Similar Documents

Publication Publication Date Title
AU2001279134A1 (en) Nucleotide incorporating enzymes
AU2520901A (en) Keyboard arrangement
AU2001228708A1 (en) Coin-validation arrangement
AU2001228678A1 (en) Amplifier arrangement
EP1130098A3 (en) Mammalian osteoregulins
AU2002230669A1 (en) Postmortem stem cells
AU2001244570A1 (en) Writing implement
AU2001286315A1 (en) Stem cell-like cells
AU2001235452A1 (en) Cell culture media
AU2002220553A1 (en) Bioreactor
AU2001278753A1 (en) Air-hydrogen cell
AU2001242755A1 (en) Writing implement
AU2001288121A1 (en) Enzyme electrode
AU2001244646A1 (en) Small drill
AU2001295793A1 (en) Pluripotential stem cells
AU2002214083A1 (en) Secure keyboard
AU2001250966A1 (en) Pluripotential stem cells
AU2001268399A1 (en) Toxicity typing using mesenchymal stem cells
AU2001264247A1 (en) GASC1 gene
AU2001294010A1 (en) Stem cells
AU2001247444A1 (en) Erbeta-mediated gene expression
AU2001285743A1 (en) Adipose-related gene
AU4974800A (en) Eosinophil degranulating conditions
AU2002224444A1 (en) Therapeutic uses for mesenchymal stromal cells
AUPR056200A0 (en) Communication arrangement